Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Technical standards and guidelines for Huntington disease testing.

Nicholas T Potter1, Elaine B Spector, Thomas W Prior

  • 1Molecular Subcommittee of the Laboratory Quality Assurance Committee, Huntington Disease Molecular Working Group, and Laboratory Quality Assurance Committee, Bethesda, Maryland, USA.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|January 17, 2004
PubMed
Summary

The American College of Medical Genetics and Genomics (ACMG) provides updated guidelines for Huntington Disease (HD) testing. These guidelines offer flexibility for laboratory directors using various molecular genetics platforms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical <i>SMN1</i> and <i>SMN2</i> Gene-Specific Sequencing to Enhance the Clinical Sensitivity of Spinal Muscular Atrophy Diagnostic Testing.

Human mutation·2025
Same author

Pathogenic variants in GCSH encoding the moonlighting H-protein cause combined nonketotic hyperglycinemia and lipoate deficiency.

Human molecular genetics·2022
Same author

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial.

Leukemia·2022
Same author

An LMNA synonymous variant associated with severe dilated cardiomyopathy: Case report.

American journal of medical genetics. Part A·2021
Same author

Characterization of Prion Disease Associated with a Two-Octapeptide Repeat Insertion.

Viruses·2021
Same author

Molecular landscape and prognostic impact of FLT3-ITD insertion site in acute myeloid leukemia: RATIFY study results.

Leukemia·2021

Area of Science:

  • Molecular Genetics
  • Clinical Laboratory Science

Background:

  • The ACMG Laboratory Quality Assurance (QA) Committee aims to establish standards for clinical genetics laboratories.
  • The Huntington Disease (HD) Working Group, under the Molecular Subcommittee, developed these guidelines.

Purpose of the Study:

  • To provide helpful, non-restrictive guidelines for Huntington Disease (HD) testing.
  • To offer technique-specific guidance for commonly used HD testing technologies.

Main Methods:

  • Development of guidelines by the HD Working Group.
  • Inclusion of technique-specific information for current commercial HD testing platforms.

Main Results:

  • Guidelines are intended as a helpful resource, not a rigid mandate.

Related Experiment Videos

  • Laboratory directors retain flexibility in choosing testing platforms and strategies.

    • Conclusions:

    • These guidelines support quality assurance in molecular genetics testing for HD.
    • The document acknowledges that technologies evolve and may necessitate future revisions.